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Purpose: As originally demonstrated by the Framingham Study, high density lipoprotein (HDL) 
cholesterol levels are inversely associated with cardiovascular risk. In the present study, we investigated 
the effect of different levels of HDL cholesterol on the outcome of patients with known coronary heart 
disease (CHD).  
Methods: We prospectively examined 2322 consecutive patients (age 67±10 years, 79% male) with 
chronic CHD, defined by a >50% coronary stenosis and/or a previous myocardial infarction (MI). HDL 
cholesterol levels were low (<35 mg/dL) in 736 patients (32%), normal (35-60 mg/dL) in 1464 (63%), 
high (>60 mg/dL) in 122 (5%).  
Results: During follow-up (median 46 months), 223 patients (9.6%) developed a cardiac event: cardiac 
death in 143 patients and non-fatal MI in 80. As expected, cardiac event-free survival was lower in 
patients with low compared to normal HDL cholesterol (hazard ratio [HR] 1.98, 95% confidence interval 
[CI] 1.5 to 2.6, p <0.0001). Surprisingly, event-free survival was also lower in patients with high HDL 
compared to normal HDL cholesterol (HR 1.78, 95% CI 1.03 to 2.87, p = 0.039). The prognostic impact 
of low HDL cholesterol persisted (p <0.0001) after adjustment for age, sex, diabetes mellitus, left 
ventricular systolic function, extent of coronary stenoses, LDL cholesterol, triglycerides, complete blood 
count, thyroid and renal function. Conversely, the impact of elevated HDL cholesterol disappeared (p = 
0.40) after adjustment for age, body mass index, thyroid dysfunction and left ventricular ejection 
fraction. Despite being less frequently male (p <0.001), obese (p <0.05) and diabetic (p < 0.05) 
patients with elevated HDL cholesterol were 3 years older than those with normal HDL and 5 years older 
than those with low HDL cholesterol (p <0.0001).  
Conclusions: Although elevated HDL cholesterol is not associated with cardiac event-free survival at 
multivariate analysis, patients with elevated HDL cholesterol develop cardiac events similarly to those 
with low HDL, but at a more advanced age.  
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